Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Hospitalization Patterns with Commercial CAR T-Cell Therapy: A Single Institution Experience

Sunita Dwivedy Nasta, MD, Esin C. Namoglu, B.S., Mitchell E. Hughes, PharmD, Elise A. Chong, MD, Jakub Svoboda, MD, Hatcher J. Ballard, BS, Daniel J. Landsburg, MD, Meredith I LaRose, MD, Stefan K. Barta, MD MRCP, MS, James N. Gerson, MD, Marco Ruella, MD, Noelle V. Frey, MD, Stephen J. Schuster, MD, David L. Porter, MD

Blood (2019) 134 (Supplement_1): 3240.

https://doi.org/10.1182/blood-2019-130650

Published: 2019

Journal Articles

A Retrospective Review of Tocilizumab for the Management of Blinatumomab (a Bispecific T Cell Engager)-Induced Cytokine Release Syndrome (CRS)

Jessica Choudhry, PharmD, RPh, Mandy Parson, BSN, Jacqueline Wright

Blood (2018) 132 (Supplement 1): 5211.

https://doi.org/10.1182/blood-2018-99-117353

Published: 2018

Journal Articles

Allogeneic CAR-T Cell Therapy for Treatment of Relapse after Allo-HSCT in Patients with Refractory CML Lymphoid Blast Crisis: Significance of HLA Matched Donor/Patient Pair in the Safety/Efficacy of CAR-T Cell Therapy

Kai Sun, MD, Xuejun Zhang, MD, Zhen Wang, MD, Yuqing Chen, MD, Lei Zhang, MD, Wei Cheng, MD, Mingyue Shi, MD, Lei Huo, MD, Yanliang Bai, MD, Xiaona Niu, MD, Honggang Guo, MD, Jing Yang, MD, Chunrong Tong, MD, AlexH Chang, MD, PhD

Blood (2018) 132 (Supplement 1): 4275.

https://doi.org/10.1182/blood-2018-99-115768

Published: 2018

Journal Articles

Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation: The Role of Calcineurin Inhibitors

Elisa Sala, MD, Stephanie von Harsdorf, MD, Verena Wais, MD, Thanh Mai Anne Nguyen, MD, Raphael Beck, MD, Hartmut Döhner, MD, Donald Bunjes, MD, Florian Kuchenbauer, MD PhD

Blood (2018) 132 (Supplement 1): 4601.

https://doi.org/10.1182/blood-2018-99-114977

Published: 2018

Journal Articles

Differentiating Fat Embolism Syndrome Due to Bone Marrow Necrosis in Patients with Sickle Hemoglobinopathies from Thrombotic Thrombocytopenic Purpura (TTP)

Radhika Gangaraju, MD, Jori May, MD, Paul MacLennan, PhD, Vishnu V.B. Reddy, MD, Marisa B. Marques, MD

Blood (2018) 132 (Supplement 1): 1090.

https://doi.org/10.1182/blood-2018-99-112621

Published: 2018

Journal Articles

Polatuzumab Vedotin Combined with Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone (G-CHP) for Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Updated Results of a Phase Ib/II Study

Andres Forero-Torres, MD, Kathryn S. Kolibaba, MD, Herve Tilly, Gilles Salles, MD PhD, Lijia Wang, Calvin Lee, Jeffrey P. Sharman, MD

Blood (2017) 130 (Supplement 1): 4120.

https://doi.org/10.1182/blood.V130.Suppl_1.4120.4120

Published: 2017

Journal Articles

Successful Treatment of Macrophage Activation Syndrome in Chronic Lymphoproliferative Disorder of Natural Killer Cells with Cyclophosphamide

Deepa Jeyakumar, MD, Sarmen Sarkissian, MD, Parwiz Siaghani, DO, Sherif Rezk, MD

Blood (2015) 126 (23): 5073.

https://doi.org/10.1182/blood.V126.23.5073.5073

Published: 2015

Journal Articles

Blinatumomab for Relapsed/Refractory Acute Lymphocytic Leukemia: A Single Center Experience

Tara L. Lin, MD, Zahra Mahmoudjafari, PharmD, Omar S. Aljitawi, MD, Anurag K. Singh, MD, Leyla Shune, MD, Siddhartha Ganguly, MD, Sunil Abhyankar, MD, Joseph McGuirk, DO

Blood (2015) 126 (23): 4912.

https://doi.org/10.1182/blood.V126.23.4912.4912

Published: 2015

Journal Articles

Rare Presentation of Relapsed Extranasal Natural Killer/T Cell Leukemia Lymphoma Involving the Hypothalamus

Byung Moon Kim, MD, Mohsin Malik, MD MBBS, Todd F. Roberts, MD MSC, FRCP (C)

Blood (2015) 126 (23): 5012.

https://doi.org/10.1182/blood.V126.23.5012.5012

Published: 2015

Journal Articles

A Phase I Study of IGN523, a Novel Anti-CD98 Monoclonal Antibody in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)

Dale Bixby, MD PhD, Matthew J. Wieduwilt, MD PhD, Luke Paul Akard, MD, H. Jean Khoury, MD, Pamela S. Becker, MD PhD, Edward H. Van Der Horst, PhD, William Ho, MD PhD, Jorge E. Cortes, MD

Blood (2015) 126 (23): 3809.

https://doi.org/10.1182/blood.V126.23.3809.3809

Published: 2015

Journal Articles

Successful Eculizumab Therapy in Thrombotic Thrombocytopenic Purpura (TTP) Refractory to Plasma Exchange, Steroids and Rituximab

Harjot Kaur, MD, Appalanaidu Sasapu, MD MS, Michele H Fox, MD, Pooja Motwani, MD

Blood (2014) 124 (21): 2794.

https://doi.org/10.1182/blood.V124.21.2794.2794

Published: 2014

Journal Articles

Atypical Hemolytic Uremic Syndrome Associated with Deferasirox (Exjade)

Vamsi Koduri, MD MPH, Douglas K. Hawley, MD

Blood (2014) 124 (21): 5025.

https://doi.org/10.1182/blood.V124.21.5025.5025

Published: 2014

Journal Articles

Interim Safety Analysis: a Phase I Trial of High Dose Therapy and Autologous Stem Cell Transplantation Followed By Infusion of Chimeric Antigen Receptor Modified T-Cells (19-28z CAR-T) Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma (B-NHL)

Craig S. Sauter, MD, Isabelle Riviere, PhD, Yvette J Bernal, MS, Xiuyan Wang, PhD, Terence J. Purdon, Sarah Yoo, Craig H Moskowitz, MD, Sergio Giralt, MD, Matthew J Matasar, MD MS, Kevin J. Curran, MD, Jae H Park, MD, Michel Sadelain, MD PhD, Renier J. Brentjens, MD PhD

Blood (2014) 124 (21): 677.

https://doi.org/10.1182/blood.V124.21.677.677

Published: 2014

Journal Articles

Brentuximab Vedotin: A Promising Therapeutic Option In An HIV Patient With Advanced Hodgkin lymphoma and Significant Hyperbilirubinemia From Liver Involvement

Peter Georges, MD, Chady Abboud leon, MD, Linda Devereux, MD, Andres Ferber, MD

Blood (2013) 122 (21): 5109.

https://doi.org/10.1182/blood.V122.21.5109.5109

Published: 2013

Journal Articles

Neurologic Complications In Pediatric Sickle Cell Patients Hospitalized For Priapism: An Analysis Of The Pediatric Health Information System (PHIS) Database

Gary Jones, DO, Brian R Lee, MPH, PhD, Gerald M Woods, MD, Jignesh Dalal, MD, Ram Kalpatthi, MD

Blood (2013) 122 (21): 2237.

https://doi.org/10.1182/blood.V122.21.2237.2237

Published: 2013

Journal Articles

Safe and Effective Re-Induction Of Complete Remissions In Adults With Relapsed B-ALL Using 19-28z CAR CD19-Targeted T Cell Therapy

Blood (2013) 122 (21): 69.

https://doi.org/10.1182/blood.V122.21.69.69

Published: 2013

Journal Articles

Safety and Efficacy Of Obinutuzumab (GA101) With Fludarabine/Cyclophosphamide (G-FC) Or Bendamustine (G-B) In The Initial Therapy Of Patients With Chronic Lymphocytic Leukemia (CLL): Results From The Phase 1b Galton Trial (GAO4779g)

Jennifer R Brown, MD, PhD, Susan O'Brien, MD, C Daniel Kingsley, MD, FACP, Herbert Eradat, MS, MD, John M. Pagel, MD, PhD, James Lymp, PhD, Jamie Hirata, PharmD, Thomas J. Kipps, MD, PhD

Blood (2013) 122 (21): 523.

https://doi.org/10.1182/blood.V122.21.523.523

Published: 2013

Journal Articles

Patterns of Clinical Presenations of Thrombotic Thrombocytopenic Purpura in Plasma Exchange Era

Muath Dawod, MD, Mohammad Alhyari, MD, Philip Kuriakose, MD

Blood (2012) 120 (21): 4642.

https://doi.org/10.1182/blood.V120.21.4642.4642

Published: 2012

Journal Articles

Retrospective Analysis of the Safety and Efficacy of Brentuximab Vedotin in Patients Aged 60 Years or Older with Relapsed or Refractory CD30+ Hematologic Malignancies

Michelle A. Fanale, MD, Nancy L. Bartlett, MD, Andres Forero-Torres, MD, Anas Younes, MD, Robert W. Chen, MD, Jonathan W. Friedberg, MD, Jeffrey V. Matous, MD, Andrei R. Shustov, MD, Scott E. Smith, MD, PhD, Jasmine Zain, MD, Megan M. O'Meara, MD, Ajay K. Gopal, MD

Blood (2012) 120 (21): 3687.

https://doi.org/10.1182/blood.V120.21.3687.3687

Published: 2012

Journal Articles

Oral Azacitidine (AZA) Activity in Patients with Acute Myelogenous Leukemia (AML)

Steven D. Gore, MD, Christopher R. Cogle, MD, Barry Skikne, MD, Eric Laille, MS, Tao Shi, PhD, Kyle J. MacBeth, PhD, Heidi Giordano, MA, MBA, Guillermo Garcia-Manero

Blood (2011) 118 (21): 1546.

https://doi.org/10.1182/blood.V118.21.1546.1546

Published: 2011

NARROW

Hospitalization Patterns with Commercial CAR T-Cell Therapy: A Single Institution Experience

A Retrospective Review of Tocilizumab for the Management of Blinatumomab (a Bispecific T Cell Engager)-Induced Cytokine Release Syndrome (CRS)

Allogeneic CAR-T Cell Therapy for Treatment of Relapse after Allo-HSCT in Patients with Refractory CML Lymphoid Blast Crisis: Significance of HLA Matched Donor/Patient Pair in the Safety/Efficacy of CAR-T Cell Therapy

Central Nervous System Complications after Allogeneic Hematopoietic Stem Cell Transplantation: The Role of Calcineurin Inhibitors

Differentiating Fat Embolism Syndrome Due to Bone Marrow Necrosis in Patients with Sickle Hemoglobinopathies from Thrombotic Thrombocytopenic Purpura (TTP)

Polatuzumab Vedotin Combined with Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone (G-CHP) for Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Updated Results of a Phase Ib/II Study

Successful Treatment of Macrophage Activation Syndrome in Chronic Lymphoproliferative Disorder of Natural Killer Cells with Cyclophosphamide

Blinatumomab for Relapsed/Refractory Acute Lymphocytic Leukemia: A Single Center Experience

Rare Presentation of Relapsed Extranasal Natural Killer/T Cell Leukemia Lymphoma Involving the Hypothalamus

A Phase I Study of IGN523, a Novel Anti-CD98 Monoclonal Antibody in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)

Successful Eculizumab Therapy in Thrombotic Thrombocytopenic Purpura (TTP) Refractory to Plasma Exchange, Steroids and Rituximab

Atypical Hemolytic Uremic Syndrome Associated with Deferasirox (Exjade)

Interim Safety Analysis: a Phase I Trial of High Dose Therapy and Autologous Stem Cell Transplantation Followed By Infusion of Chimeric Antigen Receptor Modified T-Cells (19-28z CAR-T) Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma (B-NHL)

Brentuximab Vedotin: A Promising Therapeutic Option In An HIV Patient With Advanced Hodgkin lymphoma and Significant Hyperbilirubinemia From Liver Involvement

Neurologic Complications In Pediatric Sickle Cell Patients Hospitalized For Priapism: An Analysis Of The Pediatric Health Information System (PHIS) Database

Safe and Effective Re-Induction Of Complete Remissions In Adults With Relapsed B-ALL Using 19-28z CAR CD19-Targeted T Cell Therapy

Safety and Efficacy Of Obinutuzumab (GA101) With Fludarabine/Cyclophosphamide (G-FC) Or Bendamustine (G-B) In The Initial Therapy Of Patients With Chronic Lymphocytic Leukemia (CLL): Results From The Phase 1b Galton Trial (GAO4779g)

Patterns of Clinical Presenations of Thrombotic Thrombocytopenic Purpura in Plasma Exchange Era

Retrospective Analysis of the Safety and Efficacy of Brentuximab Vedotin in Patients Aged 60 Years or Older with Relapsed or Refractory CD30+ Hematologic Malignancies

Oral Azacitidine (AZA) Activity in Patients with Acute Myelogenous Leukemia (AML)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only